INT60110

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.35
First Reported 1993
Last Reported 1993
Negated 0
Speculated 0
Reported most in Abstract
Documents 2
Total Number 2
Disease Relevance 1.45
Pain Relevance 0.31

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

extracellular space (Serpinc1)
Anatomy Link Frequency
platelet 1
Serpinc1 (Rattus norvegicus)
Pain Link Frequency Relevance Heat
cva 1 97.76 Very High Very High Very High
Angina 2 96.92 Very High Very High Very High
Percutaneous transluminal coronary angioplasty 2 87.60 High High
Disease Link Frequency Relevance Heat
Disorder Of Lipid Metabolism 2 100.00 Very High Very High Very High
Thrombosis 1 98.08 Very High Very High Very High
Stable Angina Pectoris 1 96.92 Very High Very High Very High
Pathologic Constriction 4 95.56 Very High Very High Very High
Pulmonary Embolism 5 94.40 High High
Angina 1 87.68 High High
Cardiovascular Disease 16 85.48 High High
Diabetes Mellitus 1 65.52 Quite High
Hypertension 1 64.72 Quite High
Nicotine Addiction 1 63.60 Quite High

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
Through coagulation studies revealed that the concentration of antithrombin III antigen and progressive antithrombin activity were within normal limits, while heparin cofactor activity was decreased markedly.
Transcription (concentration) of antithrombin III
1) Confidence 0.35 Published 1993 Journal Nihon Kyobu Shikkan Gakkai Zasshi Section Abstract Doc Link 8515601 Disease Relevance 0.53 Pain Relevance 0.14
The following factors were thus assessed: lipid factors: cholesterol, triglycerides, high density lipoprotein cholesterol, low density lipoprotein cholesterol, apolipoprotein AI, apolipoprotein B; coagulation factors: fibrinogen, antithrombin III, fibrinopeptide A, factor VIII coagulant, factor VIII antigen, protein C; factors of physiological fibrinolysis: plasminogen, alpha 2-antiplasmin, tissue plasminogen activator and euglobulin clot lysis time before and after venous occlusion, plasminogen activator inhibitor before venous occlusion; and factors of platelet release: beta-thromboglobulin, platelet factor 4.
Transcription (assessed) of antithrombin III in platelet associated with disorder of lipid metabolism
2) Confidence 0.04 Published 1993 Journal Int. J. Cardiol. Section Abstract Doc Link 8444504 Disease Relevance 0.92 Pain Relevance 0.18

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox